Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anacor Pharmaceuticals Inc

+ Add to Watchlist


33.201 EUR 0.701 2.16%

As of 15:16:34 ET on 01/30/2015.

Company Profile for Anacor Pharmaceuticals Inc (44A)

Anacor Pharmaceuticals Inc. is a biopharmaceutical company developing small-molecule therapeutics derived from our boron chemistry platform. The Company is focused on developing topical applications to treat fungal, bacterial and inflammatory diseases.

Contact Information

Anacor Pharmaceuticals Inc

1020 East Meadow Circle
Palo Alto, CA 94303-4230
United States
Phone: 1-650-543-7500
Fax: 1-650-543-7660

Key Executives for Anacor Pharmaceuticals Inc (44A)

Paul L BernsPresident/CEOVincent P IppolitoExec VP/Chief Commercial Ofcr
Geoffrey M ParkerSenior VP/CFOKirk R MaplesSenior VP:Program Management
Sanjay ChandaVP/Interim Head:Drug DevLee T ZaneVP:Clinical Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil